Corporate News     08-Mar-22
Aleor Dermaceuticals receives USFDA approval for Nystatin and Triamcinolone Acetonide Ointment
Alembic Pharmaceuticals (Alembic) today announced that its joint venture Aleor Dermaceuticals (Aleor) has received final approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Nystatin and Triamcinolone Acetonide Ointment USP, 100,000 units/gram. The approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Nystatin and Triamcinolone Acetonide Ointment USP, 100,000 U/g/0.1 %, of Taro Pharmaceuticals U.S.A. Inc. Nystatin and Triamcinolone Acetonide Ointment is indicated for the treatment of cutaneous candidiasis; it has been demonstrated that the nystatin-steroid combination provides greater benefit than the nystatin component alone during the first few days of treatment.
Previous News
  Alembic Pharmaceuticals announces board meeting date
 ( Corporate News - 19-Jan-24   14:13 )
  CRISIL reaffirms ratings of Alembic Pharmaceuticals with 'stable' outlook
 ( Hot Pursuit - 08-Mar-24   11:22 )
  Alembic Pharmaceuticals receives USFDA approval for Doxycycline Capsules
 ( Corporate News - 28-Jun-24   13:38 )
  Alembic Pharmaceuticals consolidated net profit rises 596.17% in the March 2023 quarter
 ( Results - Announcements 05-May-23   17:32 )
  Volumes soar at Alembic Pharmaceuticals Ltd counter
 ( Hot Pursuit - 02-Jan-24   14:30 )
  Alembic Pharma suspends Sikkim facility operations due to floods
 ( Hot Pursuit - 04-Oct-23   14:39 )
  Alembic Pharma Q4 PAT zooms to Rs 153 cr; R&D spend at Rs 136 crore
 ( Hot Pursuit - 06-May-23   14:44 )
  Alembic Pharm gets US FDA approvals for five products in Q1 FY24
 ( Hot Pursuit - 03-Jul-23   09:54 )
  Alembic Pharmaceuticals to convene board meeting
 ( Corporate News - 21-Jul-22   15:01 )
  Alembic Pharma
 ( Results - Analysis 26-Jul-21   18:02 )
  Alembic Pharma gains as Karkhadi facility gets EIR from USFDA
 ( Hot Pursuit - 16-Feb-23   15:42 )
Other Stories
  Ugro Capital to raise Rs 75 cr via NCD issuance
  06-Jul-24   10:58
  Board of D.P. Abhushan approves preferential allotment of shares and warrants
  06-Jul-24   10:50
  Life Insurance Corporation of India invest Rs 14 cr in Sri Lankan subsidiary
  06-Jul-24   10:49
  High Energy Batteries (India) to discuss results
  06-Jul-24   10:29
  Havells India schedules board meeting
  06-Jul-24   10:29
  Axis Bank announces board meeting date
  06-Jul-24   10:29
  Mastek to conduct board meeting
  06-Jul-24   10:29
  Oriental Hotels to conduct board meeting
  06-Jul-24   10:29
  Milkfood schedules AGM
  06-Jul-24   10:28
  Transcorp International to table results
  06-Jul-24   10:28
Back Top